Categories
Archives
Receive Email Updates
-
-
-
Certified Licensing Professionals, Inc., 2021 
Disclaimer
This blog, Patents4Life, does not contain legal advice and is for informational purposes only. Its publication does not create an attorney-client relationship nor is it a solicitation for business. This is the personal blog of Warren Woessner and does not reflect the views of Schwegman Lundberg & Woessner, or any of its attorneys or staff. To the best of his ability, the Author provides current and accurate information at the time of each post, however, readers should check for current information and accuracy.
-
- About Me
Warren D. Woessner
Pages
Archives
Author Archives: Warren Woessner
Should the Australian Patent Office be denying patent eligibility to cDNA inventions?
This is a guest post from Grant Shoebridge of Shelston IP. In this, the first of a trilogy of articles investigating specific areas of Australian Patent Office examination practice, I consider how the High Court’s decision in D’Arcy v Myriad Genetics Inc … Continue reading
Posted in Australian Practice, BIO
Leave a comment
New Webinar Series: Practical IP for Natural Sciences
Please join us in a new webinar series directed to the practical strategies in a new era of patent law to protect IP in chemistry, pharmaceuticals, biotechnology and genetic medicine. The collision of new technologies and patent statutes of a … Continue reading
Posted in Webinar
Tagged Chemical, intellectual property, Life Science, Life Sciences, Myriad, Natural Sciences, Patent Prosecution
Leave a comment
Athena Diagnostics, Inc. v. Mayo (D. Mass., August 4, 2017) – “That’s all,” She Wrote.
Please read my recent post about stage 1 of this proceeding, in which the Judge in 2016 found that the claims to diagnosing Myasthemia Gravis (MG) by adding MuSk to a patient sample and detecting any IgG autoantibody complexes that … Continue reading
Posted in Patent Eligible Subject Matter
Tagged Alice, Binary Complexes, Mayo, MuSK, Myriad
Leave a comment
Athena Diagnostics v. Mayo – Finessing the Correlations Trap?
In The Cleveland Clinic Foundation v. True Health Diagnostics, the Fed. Cir. panel held that a claim to a diagnostic method for determining a test subject’s risk for atherosclerotic cardiovascular disease (CD) by comparing MPO levels in the bodily fluid … Continue reading
Posted in Patent Eligible Subject Matter
1 Comment